Advertisement

Topics

DNAPrint™ genomics, Inc. Company Profile

04:03 EDT 21st September 2018 | BioPortfolio

DNAPrint™ genomics, Inc. is a cutting edge company. We are concentrating our efforts in four distinct areas; Pharmacogenomics, Forensics, Genotyping, and Consumer Products. Our aim is to continue to research and develop novel products and services in each of these market areas and to be a leader in genomic-based technologies.
The Company’s core patent applied for and proprietary technologies for efficiently targeting single nucleotide polymorphisms (“SNPs”) enable us to provide novel predictive genetic tests at a significant cost advantage over our competitors.

We have identified and applied for patenteds to cover the maps of certain SNPs that we believe have broad commercial applications. These commercially valuable SNPs are called Ancestry Informative Markers (“AIMs”) and are an integral part of our proprietary Admixture Mapping (“Mapping”) method. With our mapping, we leverage known statistical data about population structure to substantially reduce the number of SNPs analyzed and therefore more cost effectively identify genes responsible for certain traits. Our proprietary data and analytical resources for using AIMs are integral to our strategy of offering DNA tests that provide value in other ways too – from better study design using more traditional methods, and generating valuable predictive results, including a person’s physical characteristics, BioGeographical Ancestry (“BGA”), and predisposition to respond to certain pharmaceutical drugs.

Location

900 Cocoanut Ave.
Sarasota
Florida
34236
United States of America

Contact

Phone: (941) 366-3400
Fax: (941) 952-9770
Email: info@dnaprint.com


News Articles [341 Associated News Articles listed on BioPortfolio]

Genomics England announces appointment of global genomics pioneer as first CEO

Genomics England announces the appointment of its first Chief Executive Officer (CEO) today. Global genomics pioneer Professor John Mattick will join Genomics England in June. He will lead the organiz...

Rosetta Genomics Ltd.: Genoptix Completes Acquisition of PersonalizeDx from Rosetta Genomics

-First step in the process of Genoptix acquiring all of Rosetta Genomics -Next step is the completion of a merger for $8 million in cash pursuant to which value to Rosetta Genomics' equity holders...

UCSF Names First Chief Genomics Officer

David RathsRecognizing that genomics is playing an increasingly important role in medicine, the University of California San Francisco Health has appointed its first chief genomics officer (CGO).

Festival of Genomics London 2018: the landmark event making genomics mainstream

London, UK, 5th January 2018 / Sciad Newswire / This January sees the third edition of Festival of Genomics London, the largest meeting of its kind in the UK. Following two US editions of the event ...

Rosetta Genomics Ltd.: Rosetta Genomics Announces Shareholder Approval of Merger with Genoptix

PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / April 26, 2018 / Rosetta Genomics Ltd. (the "Company") (NASDAQ: ROSG) today announced that its shareholders approved a proposed merger with a sub...

Verge joins Genomics England’s Discovery Forum industry partnership

Genomics England and Verge Genomics, a leading artificial intelligence therapeutics company, announced today that Verge will join Genomics England’s Discovery Forum industry partnership. The partner...

#jobs #lifescience CK Group: Genomics Manufacturing Technician – Hertfordshire

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: CK Group: Genomics Manufacturing Technician – Hertfordshire . £18,000:...

10x Genomics Raises $125M toward New Product Launches, Commercial Expansion

10x Genomics said it will use a combined $125 million in new funding toward the development and launch of new products, as well as continued expansion of its commercial operations. The new funding...

Drugs and Medications [0 Results]

None

Clinical Trials [87 Associated Clinical Trials listed on BioPortfolio]

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients

The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and a...

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

This pilot clinical trial studies whether using high throughput drug sensitivity and genomics data is feasible in developing individualized treatment in patients with multiple myeloma or p...

Inflammatory Genomics in Human Carotid Artery Disease

To investigate the relationship between genetic variation in genes for inflammation and carotid artery atherosclerosis.

Companies [405 Associated Companies listed on BioPortfolio]

DNAPrint™ genomics, Inc.

DNAPrint™ genomics, Inc. is a cutting edge company. We are concentrating our efforts in four distinct areas; Pharmacogenomics, Forensics, Genotyping, and Consumer Products. Our aim is to continue to...

Genomics in Business

In 2003 Keygene initiated the first edition of Genomics in Business. It was the first conference to focus on the existing and future applications of genomics in the Agro-Food industry. With participan...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

Center for Genomics and Bioinformatics

Center for Genomics and Bioinformatics The Center for Genomics and Bioinformatics (CGB) was launched in 1997 as a new academic department at the Karolinska Institute. Since then, the department has be...

Front Line Genomics

At Front Line Genomics our mission is to help deliver the benefits of genomics faster. Through our website, our magazine and the Festivals of Genomics, we support scientists, clin...

More Information about "DNAPrint™ genomics, Inc." on BioPortfolio

We have published hundreds of DNAPrint™ genomics, Inc. news stories on BioPortfolio along with dozens of DNAPrint™ genomics, Inc. Clinical Trials and PubMed Articles about DNAPrint™ genomics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DNAPrint™ genomics, Inc. Companies in our database. You can also find out about relevant DNAPrint™ genomics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record